Jubilant Ingrevia Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Deepak Jain
Chief executive officer
₹127.7m
Total compensation
| CEO salary percentage | 18.00% |
| CEO tenure | 2.1yrs |
| CEO ownership | 0.01% |
| Management average tenure | 2.1yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Jubilant Ingrevia (NSE:JUBLINGREA) Shareholders Will Want The ROCE Trajectory To Continue
Nov 07
Are Investors Undervaluing Jubilant Ingrevia Limited (NSE:JUBLINGREA) By 38%?
Oct 17The Price Is Right For Jubilant Ingrevia Limited (NSE:JUBLINGREA)
Sep 20We Like These Underlying Return On Capital Trends At Jubilant Ingrevia (NSE:JUBLINGREA)
Jul 03Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Pretty Bullish On The Stock After Recent Results
May 16Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Share Price Matching Investor Opinion
Apr 22
International Expansion And New Vitamin B3 Facility Will Boost Presence In High-Value Products
Specialty Chemicals and Nutrition & Health segments are poised for growth, boosting revenue and margins through high-margin chemicals and vitamin B3 production.Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50
Feb 01Results: Jubilant Ingrevia Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Jan 31Is Jubilant Ingrevia (NSE:JUBLINGREA) Using Too Much Debt?
Dec 18We Think Jubilant Ingrevia (NSE:JUBLINGREA) Is Taking Some Risk With Its Debt
Sep 11Jubilant Ingrevia (NSE:JUBLINGREA) Is Reinvesting At Lower Rates Of Return
Aug 14Jubilant Ingrevia Limited Just Missed Earnings - But Analysts Have Updated Their Models
Jul 19Earnings Tell The Story For Jubilant Ingrevia Limited (NSE:JUBLINGREA) As Its Stock Soars 29%
Apr 13Jubilant Ingrevia Limited Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
Feb 02A Look At The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)
Feb 01Returns At Jubilant Ingrevia (NSE:JUBLINGREA) Are On The Way Up
Oct 19Market Cool On Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Earnings
Jun 08Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50
Feb 03Investors Should Be Encouraged By Jubilant Ingrevia's (NSE:JUBLINGREA) Returns On Capital
Dec 14Calculating The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)
Oct 07Jubilant Ingrevia Limited Just Missed Revenue By 86%: Here's What Analysts Think Will Happen Next
May 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | ₹3b |
| Jun 30 2025 | n/a | n/a | ₹3b |
| Mar 31 2025 | ₹128m | ₹23m | ₹3b |
| Dec 31 2024 | n/a | n/a | ₹2b |
| Sep 30 2024 | n/a | n/a | ₹2b |
| Jun 30 2024 | n/a | n/a | ₹2b |
| Mar 31 2024 | ₹38m | ₹11m | ₹2b |
Compensation vs Market: Deepak's total compensation ($USD1.44M) is above average for companies of similar size in the Indian market ($USD541.08K).
Compensation vs Earnings: Deepak's compensation has increased by more than 20% in the past year.
CEO
Deepak Jain (44 yo)
Mr. Deepak Jain serves as Chief Executive Officer, Managing Director and Director at Jubilant Ingrevia Limited since October 01, 2023. He has rich & diverse global experience with Bain & Company, where he...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Chairman & Whole-Time Director | 4.8yrs | ₹184.04m | 0.31% ₹ 346.1m | |
| CEO, MD & Director | no data | ₹127.68m | 0.014% ₹ 15.2m | |
| Chief of Operations & Whole Time Director | no data | ₹8.62m | no data | |
| President & CFO | 1.3yrs | no data | no data | |
| Company Secretary & Compliance Officer | 5.3yrs | ₹4.62m | no data | |
| Executive VP & Head of Legal | no data | no data | no data | |
| Senior VP & Head of Human Resources | no data | ₹15.37m | no data | |
| Business Head of Animal & Human Nutrition | no data | ₹15.53m | no data | |
| President of Speciality Chemicals | no data | no data | no data | |
| Business Head of Acetyls | 2.1yrs | no data | no data | |
| VP and Head of Quality & Regulatory Affairs | no data | no data | no data | |
| Senior VP & Head of Supply Chain | 1.2yrs | no data | no data |
Experienced Management: JUBLINGREA's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Chairman & Whole-Time Director | 4.8yrs | ₹184.04m | 0.31% ₹ 346.1m | |
| CEO, MD & Director | 2.1yrs | ₹127.68m | 0.014% ₹ 15.2m | |
| Chief of Operations & Whole Time Director | 1yr | ₹8.62m | no data | |
| Chairman | 4.8yrs | ₹1.50m | 0.0032% ₹ 3.5m | |
| Independent Non-Executive Director | 4.8yrs | ₹3.05m | no data | |
| Independent Non-Executive Director | 4.8yrs | ₹3.05m | 0.0013% ₹ 1.4m | |
| Non-Executive Director | 4.8yrs | no data | 0.88% ₹ 987.3m | |
| Independent Non-Executive Director | 4.8yrs | ₹3.28m | 0.00068% ₹ 759.3k | |
| Additional Non-Executive Director | less than a year | no data | no data | |
| Independent Director | 4.6yrs | ₹3.28m | no data | |
| Independent Non-Executive Director | 4.8yrs | ₹2.68m | no data | |
| Independent Non-Executive Director | 4.8yrs | ₹3.20m | no data |
Experienced Board: JUBLINGREA's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/18 00:51 |
| End of Day Share Price | 2025/11/18 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jubilant Ingrevia Limited is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Asian Markets Securities Private Limited |
| Satish Kumar | CGS International |
| Siddharth Gadekar | Equirus Securities Private Limited |